Sanofi (SNY)
NASDAQ: SNY · IEX Real-Time Price · USD
48.54
-1.05 (-2.12%)
At close: Jul 2, 2024, 4:00 PM
45.98
-2.56 (-5.27%)
After-hours: Jul 2, 2024, 4:57 PM EDT
Sanofi Revenue
In the year 2023, Sanofi had annual revenue of $51.60B with 6.87% growth.
Revenue (ttm)
$51.60B
Revenue Growth
+6.87%
P/S Ratio
2.36
Revenue / Employee
$599,438
Employees
86,088
Market Cap
121.63B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51.60B | 3.32B | 6.87% |
Dec 31, 2022 | 48.29B | 3.77B | 8.47% |
Dec 31, 2021 | 44.52B | -1.05B | -2.31% |
Dec 31, 2020 | 45.57B | 3.29B | 7.78% |
Dec 31, 2019 | 42.28B | 1.27B | 3.11% |
Dec 31, 2018 | 41.01B | -2.46B | -5.66% |
Dec 31, 2017 | 43.47B | 6.95B | 19.04% |
Dec 31, 2016 | 36.51B | -1.35B | -3.56% |
Dec 31, 2015 | 37.86B | -853.69M | -2.20% |
Dec 31, 2014 | 38.72B | -4.31B | -10.02% |
Dec 31, 2013 | 43.03B | -4.40B | -9.28% |
Dec 31, 2012 | 47.43B | 2.05B | 4.51% |
Dec 31, 2011 | 45.38B | -122.13M | -0.27% |
Dec 31, 2010 | 45.51B | 723.08M | 1.61% |
Dec 31, 2009 | 44.78B | 4.62B | 11.51% |
Dec 31, 2008 | 40.16B | -2.53B | -5.93% |
Dec 31, 2007 | 42.69B | 3.89B | 10.03% |
Dec 31, 2006 | 38.80B | 5.11B | 15.17% |
Dec 31, 2005 | 33.69B | 12.36B | 57.92% |
Dec 31, 2004 | 21.33B | 11.20B | 110.50% |
Dec 31, 2003 | 10.13B | 2.32B | 29.67% |
Dec 31, 2002 | 7.82B | 2.05B | 35.52% |
Dec 31, 2001 | 5.77B | 185.24M | 3.32% |
Dec 31, 2000 | 5.58B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cigna | 206.00B |
Elevance Health | 171.75B |
Pfizer | 55.09B |
Medtronic | 32.36B |
Amgen | 29.53B |
Stryker | 20.96B |
Boston Scientific | 14.71B |
Regeneron Pharmaceuticals | 13.10B |
SNY News
- 1 day ago - Sanofi eyes German insulin investment of up to $1.6 bln, source says - Reuters
- 1 day ago - Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says - Reuters
- 5 days ago - German vaccine panel endorses Astra-Sanofi's RSV shot for infants - Reuters
- 6 days ago - Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM - GlobeNewsWire
- 6 days ago - Sanofi-backed Formation Bio raises $372 million in late-stage funding round - Reuters
- 6 days ago - Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC - Benzinga
- 7 days ago - Press Release: Availability of the Q2 2024 Aide-mémoire - GlobeNewsWire
- 11 days ago - Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi's Executive Committee - GlobeNewsWire